Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: https://lnkd.in/gaxhxyvZ #PatientAdvocacy #PatientInsights
Lori Preuit Dorer’s Post
More Relevant Posts
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: https://lnkd.in/eExWxV3W #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: https://lnkd.in/drXbBh7m #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: https://lnkd.in/ewiXEvvG #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: https://lnkd.in/euai9nQG #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Parexel recently hosted its first ever Patient Advocacy Group Forum, focusing on how socioeconomic status impacts clinical trial participation. The meeting focused on insights from a Parexel-sponsored survey of 4,000+ patients to better understand barriers to access and foster inclusivity. 📊 Watch below to learn how Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 🤝 Interested in the survey insights? Find them here: #PatientAdvocacy #PatientInsights
To view or add a comment, sign in
-
Assess how bringing a #commercial perspective to clinical trial recruitment can enhance communications. Leverage #patient advocacy groups to reach and educate patients. Join Farrell Simon at "Commercial's Role in Clinical Trial Recruitment." View the agenda: https://ow.ly/1Gtw50STWKk Register & save $200 with early bird (offer about to expire): https://ow.ly/6jhI50STWKl #DGEvents #CCOSummit
To view or add a comment, sign in
-
Empower change in clinical trial recruitment! 🌟 Join WeHealth on a transformative journey where patients lead the way to engagement, diversity and innovation. 🚀 Discover how our grassroots advocacy is reshaping patient recruitment, creating a more inclusive and effective approach for clinical trial leaders. Let's revolutionize together! #WeHealthInnovation #ClinicalTrialDiversity #PatientsLeadTheWay
To view or add a comment, sign in
-
Traditional methods used to understand patients' needs can only go so far. Now, the rise of Al holds the keys to uncovering critical insights about patients' needs and how to better communicate with them. Learn how Al can improve patient engagement and advocacy from our own Eleanor Dickinson and Abi Drabble via PRWeek: https://bit.ly/45XPwI5
To view or add a comment, sign in
-
How will the #IRA and other key regulatory and policy activities shaping benefit design and cost sharing impact patients? In a recent webinar, #AvalereExperts discussed #patient access and affordability efforts from manufacturers, foundations, and patient advocacy organizations. Watch the full conversation here: https://lnkd.in/eb-aB-x9 Moderated by Ayesha Azam, with speakers Mark Gooding, Lisa Joldersma, Brigit Kyei-Baffour, MBA, and Kylie Stengel.
To view or add a comment, sign in
It’s inspiring to see initiatives like this, addressing the real barriers in clinical trial participation. How do you see the insights from your survey changing the approach to future trials?